About
Anlon Healthcare Limited manufactures and sells active pharmaceutical ingredients in India and internationally. The company also offers bulk drugs; advanced pharmaceutical intermediates; nutraceutical API products; and drug intermediates. It also manufactures loxoprofen sodium dihydrate, ketoprofen, and dexketoprofen trometamol products for pain management and anti-inflammatory therapies. Anlon Healthcare Limited was incorporated in 2013 and is based in Rajkot, India.
Key Metrics
as of Sep 2026Market Cap833 Cr
P/E26.40
Div Yield0.00 %
Book Value₹4.33
52w High₹17.30
52w Low₹9.24
Face Value₹2.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.98 | 55.42 | 35.58 | 52.20 | 33.30 | 48.93 | 9.36 | 24.17 | 37.83 |
| Expenses | 23.52 | 41.51 | 23.30 | 38.46 | 27.06 | 31.74 | 8.78 | 16.65 | 30.98 |
| Operating Profit | 7.46 | 13.91 | 12.28 | 13.74 | 6.24 | 17.19 | 0.58 | 7.52 | 6.85 |
| OPM % | 24.08 | 25.10 | 34.51 | 26.32 | 18.74 | 35.13 | 6.20 | 31.11 | 18.11 |
| Other Income | 0.06 | 0.01 | 0.20 | 0.03 | 0.01 | 0.04 | 0.02 | 0.05 | 0.06 |
| Depreciation | 0.66 | 0.13 | 0.35 | 0.45 | 0.43 | 0.83 | 0.00 | 0.47 | 0.47 |
| Interest | 0.96 | 1.18 | 1.51 | 0.87 | 0.82 | 0.91 | 0.89 | 0.93 | 0.98 |
| Profit before tax | 5.90 | 12.61 | 10.62 | 12.45 | 5.00 | 15.49 | -0.29 | 6.17 | 5.46 |
| Tax % | 18.64 | 22.36 | 51.41 | 25.14 | 29.20 | -7.49 | 758.62 | 57.86 | 16.85 |
| Net Profit | 4.80 | 9.79 | 5.15 | 9.32 | 3.55 | 16.65 | -2.49 | 2.59 | 4.54 |
| EPS in Rs | 0.09 | 0.18 | 0.10 | 0.18 | 0.09 | 0.42 | -0.06 | 0.06 | 0.28 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Sales | 176.00 | 120.00 | 66.00 | 113.00 | 57.00 | 16.00 |
| Expenses | 130.00 | 88.00 | 51.00 | 100.00 | 52.00 | 21.00 |
| Operating Profit | 46.00 | 32.00 | 16.00 | 13.00 | 6.00 | -5.00 |
| OPM % | 26.00 | 27.00 | 24.00 | 11.00 | 10.00 | -32.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 |
| Depreciation | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Profit before tax | 41.00 | 27.00 | 10.00 | 7.00 | 0.00 | -10.00 |
| Tax % | 32.00 | 24.00 | 1.00 | 17.00 | 0.00 | 3.00 |
| Net Profit | 28.00 | 21.00 | 10.00 | 6.00 | 0.00 | -10.00 |
| EPS in Rs | 0.52 | 0.51 | 0.60 | 0.48 | -0.01 | -0.85 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Equity Capital | 53.00 | 40.00 | 16.00 | 12.00 | 12.00 | 12.00 |
| Reserves | 157.00 | 41.00 | 5.00 | -5.00 | -10.00 | -10.00 |
| Borrowings | 46.00 | 67.00 | 81.00 | 70.00 | 62.00 | 54.00 |
| Other Liabilities | 62.00 | 34.00 | 26.00 | 34.00 | 21.00 | 16.00 |
| Total Liabilities | 317.00 | 181.00 | 128.00 | 112.00 | 85.00 | 71.00 |
| Fixed Assets | 40.00 | 23.00 | 27.00 | 26.00 | 27.00 | 29.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 10.00 | 1.00 | 1.00 | 4.00 | 2.00 | 0.00 |
| Other Assets | 267.00 | 158.00 | 100.00 | 82.00 | 56.00 | 43.00 |
| Total Assets | 317.00 | 181.00 | 128.00 | 112.00 | 85.00 | 71.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | -36.00 | -22.00 | -3.00 | -3.00 | -2.00 | -15.00 |
| Cash from Investing Activity | -28.00 | 2.00 | -3.00 | 0.00 | 0.00 | -2.00 |
| Cash from Financing Activity | 76.00 | 19.00 | 8.00 | 2.00 | 3.00 | 16.00 |
| Net Cash Flow | 12.00 | -1.00 | 2.00 | -1.00 | 1.00 | -2.00 |
| Free Cash Flow | -55.00 | -19.00 | -7.00 | -3.00 | -2.00 | -15.00 |
| CFO/OP % | -69.00 | -85.00 | -21.00 | -23.00 | -32.00 | 291.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Debtor Days | 215.00 | 228.00 | 213.00 | 142.00 | 130.00 | 132.00 |
| Inventory Days | 245.00 | 246.00 | 452.00 | 112.00 | 225.00 | 669.00 |
| Days Payable | 128.00 | 96.00 | 217.00 | 105.00 | 128.00 | 409.00 |
| Cash Conversion Cycle | 332.00 | 377.00 | 448.00 | 149.00 | 226.00 | 392.00 |
| Working Capital Days | 321.00 | 292.00 | 261.00 | 122.00 | 163.00 | 185.00 |
| ROCE % | 22.00 | 25.00 | 15.00 | 15.00 | 7.00 | — |
Corporate Actions
2 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Split | 24 Apr 2026 | 24 Apr 2026 | 10:2 | — | |
| Bonus | 24 Apr 2026 | 24 Apr 2026 | 1:1 | — |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update4 Mar from care